HER2 expression level in breast cancers overall are only <2-fold higher than in normal breast tissues and the normal expression level of HER2 is higher than the expression levels on cancer cells of some of other ADC targets [83], which would make HER2 an unattractive target for ADC development. The gene discussed is ERBB2; the disease is breast carcinoma.